Close Menu

NEW YORK – A research study has shown that genetic testing to help guide medication decisions after a heart procedure is non-inferior to standard treatment.

Led by senior author Jurriën ten Berg of St. Antonius Hospital in Nieuwegein, the Netherlands, researchers conducting the POPular Genetics study compared a genotype-guided strategy of selecting anti-platelet medication to accompany primary percutaneous coronary intervention (PCI) with standard treatment of one of two platelet inhibitors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.